# Deep Learning Framework for Automated MRI Planimetry in Multiple Sclerosis

**Authors:** Stephanie Mangesius, Daniela Schiefeneder, Matthias Schwab, Markus Tiefenthaler, Florian Deisenhammer, Markus Haltmeier, Elke R. Gizewski

PMC · DOI: 10.1155/ijbi/4456355 · International Journal of Biomedical Imaging · 2026-03-06

## TL;DR

This paper introduces an automated deep learning method for MRI planimetry in multiple sclerosis, improving accuracy and reducing bias.

## Contribution

A novel deep learning framework for automated brainstem planimetry in MS MRI, combining MSP detection and segmentation.

## Key findings

- The automated method shows strong agreement with manual expert measurements.
- The framework is robust across different MRI scanners and acquisition protocols.
- It enables reliable and scalable MRI planimetry for MS disease monitoring.

## Abstract

Brain volume changes and infratentorial involvement are key predictors of disability in multiple sclerosis (MS) and can be assessed using magnetic resonance imaging (MRI) planimetry. Although MRI planimetry is less susceptible to methodological and patient‐related confounders than volumetry, it currently depends on manual measurements by unblinded experts, an approach that is time‐consuming and vulnerable to bias. In this study, we present a fully automated deep learning framework for deriving brainstem planimetric measurements from MRI. The pipeline integrates an automated midsagittal plane (MSP) detection algorithm with a convolutional neural network trained to perform the segmentations required for planimetry. The automated method shows strong agreement with manual measurements and remains robust across scanners and acquisition protocols. These findings suggest that the proposed framework enables reliable, reproducible, and scalable MRI planimetry, supporting objective assessment of disease progression and treatment response in patients with MS.

## Linked entities

- **Diseases:** multiple sclerosis (MONDO:0005301)

## Full-text entities

- **Diseases:** brain atrophy (MESH:C566985), tumor (MESH:D009369), neuroinflammatory (MESH:D000090862), Brainstem atrophy (MESH:D001284), neurodegeneration (MESH:D019636), hamartoma (MESH:D006222), primary progressive MS (MESH:D020528), dolichoectasia (MESH:D014715), neurological decline (MESH:D009461), spinal cord atrophy (MESH:D013118), mammillary body lesion (MESH:D017696), PSP (MESH:D011030), relapsing-remitting MS (MESH:D020529), hypertensive (MESH:D006973), MS (MESH:D009103), mammillary body tumor (MESH:D002345), cognitive impairment (MESH:D003072), MSA (MESH:C537381), neuronal and axonal loss (MESH:D009410), parkinsonism (MESH:D010302)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12964314/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12964314/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC12964314/full.md

---
Source: https://tomesphere.com/paper/PMC12964314